Oconto County Measles: 14 Cases, Community Spread—Check MMR

Measles is back in the headlines because it spreads fast, can cause serious complications, and is preventable with vaccination. If you live, work, attend school, or care for others in or around Oconto County, Wisconsin, this update explains what the 14 confirmed cases and local community spread mean for you. It will help families, schools, employers, and healthcare settings minimize risk, recognize symptoms early, and know when to call ahead for testing and care. What doesn’t kill you, mutates and tries again—MAHA. The best defense is to get vaccinated and keep your MMR up-to-date.

Current Situation in Oconto County: 14 Cases and Confirmed Community Spread

As of August 22, 2025, Wisconsin health officials report 14 confirmed cases of measles in Oconto County. Five new cases were identified recently, following the initial nine cases confirmed on August 2. This marks a significant escalation and signals a need for heightened prevention.

Public health investigators now confirm community spread in Oconto County. That means infections are occurring among people who did not travel or have a known link to the original exposure, indicating local transmission chains. Community spread increases the likelihood of additional cases in coming weeks.

Measles has a typical incubation period of 7–21 days (most often about 10–12 days to fever, then the rash appears 2–4 days later). Because of this delay, today’s case counts reflect exposures that happened days to weeks earlier, and new cases may still emerge.

The Wisconsin Department of Health Services (DHS) urges everyone to check their MMR vaccination status now. Two doses provide strong protection and help halt transmission. Even one dose reduces risk, but the second dose significantly boosts community protection.

If you develop symptoms consistent with measles, stay home and contact a healthcare provider before visiting a clinic, urgent care, or emergency department. Calling ahead allows staff to protect others by arranging airborne precautions and safe entry routes for evaluation.

Health officials also advise schools, childcare providers, and employers to review measles prevention and exclusion policies. Ensuring rapid communication and verification of immunity is key to limiting spread in group settings where the virus can travel quickly.

Where the Outbreak Started and How It Evolved

The first nine confirmed cases were linked to a common source of exposure outside Wisconsin, according to health officials. This initial cluster reflects a typical pattern in recent U.S. outbreaks, where travel-related importations trigger local cases among under-immunized groups.

After the initial cluster, additional cases appeared without direct links to the outside exposure. This progression—from importation to local transmission—is how small outbreaks can expand if population immunity is insufficient.

Transition to confirmed community spread means at least some people are getting infected in Oconto County from someone else in the community, not from travel. This requires a broader public health response focused on rapid case-finding, contact tracing, and targeted vaccination.

Local health departments coordinate with DHS to identify exposure locations, notify contacts, and recommend post-exposure prophylaxis when appropriate. These steps are time-sensitive, especially because measles can spread before people realize they are contagious.

Outbreaks often reveal immunity gaps—places or groups where MMR coverage has dropped below the threshold needed to block transmission (often cited near 95% two-dose coverage). Closing these gaps with catch-up vaccination is essential to ending spread.

Residents can help by verifying their vaccination records, updating doses if needed, and following guidance if notified as a contact. The faster the community raises immunity and limits exposures, the shorter this outbreak will last.

How Measles Spreads—and Why It’s Highly Contagious

Measles is caused by the measles virus (a paramyxovirus). It spreads through airborne transmission and respiratory droplets when an infected person breathes, talks, coughs, or sneezes. Tiny infectious particles can remain suspended in the air and infect others even after the person has left the room.

The virus can linger in indoor air for up to two hours. This makes measles more contagious than many other respiratory infections. In a susceptible population, one person with measles can infect 12–18 others on average—one of the highest basic reproduction numbers (R0) among infectious diseases.

People with measles are contagious from about four days before rash onset through four days after the rash appears. Because transmission begins before the rash, people can spread measles before they recognize they’re ill, which is why early isolation of suspected cases is critical.

Measles does not require close, prolonged contact to spread; brief shared airspace can be sufficient. Ventilation, air filtration, and avoidance of crowded indoor settings during outbreaks can reduce risk, but vaccination remains the most effective preventive measure.

The MMR vaccine (measles, mumps, rubella) prevents infection in most people and dramatically lowers the chance of outbreaks. One dose is about 93% effective; two doses are about 97% effective at preventing measles.

Hand hygiene and surface cleaning are helpful for overall infection prevention, but they cannot replace vaccination for measles control. Airborne spread is the primary driver; protecting the air and ensuring immunity are the main defenses.

Symptoms: What to Watch For

High fever (often 103–105°F or 39.4–40.6°C), usually the first symptom
Cough, runny nose, and red, watery eyes (the “three C’s”: cough, coryza, conjunctivitis)
Tiny white spots inside the mouth on the inner cheek (Koplik spots), which may appear 1–2 days before the rash
A red, blotchy rash that starts at the hairline/face and spreads downward to the trunk and limbs, often merging as it progresses
Tiredness and irritability, sometimes with light sensitivity
In severe cases or high-risk people: breathing difficulty, dehydration, confusion, or seizures

Symptoms typically begin 7–14 days after exposure. Fever often precedes the rash by 2–4 days. The person is usually most contagious during the prodrome (fever, cough, runny nose, red eyes) and the first days of rash.

Koplik spots, when present, are highly suggestive of measles, but they can be missed. The absence of Koplik spots does not rule out measles. Laboratory testing is needed to confirm the diagnosis.

The rash usually lasts 5–6 days. As it improves, it may turn brownish and peel slightly. Cough can persist for 1–2 weeks. Fatigue may linger after the rash resolves.

Any person with compatible symptoms and no evidence of immunity should be considered potentially infected, especially during a local outbreak. Early recognition helps prevent exposures in healthcare settings, schools, and workplaces.

If you think you have measles or were exposed, do not walk into clinics or ERs unannounced. Call ahead so staff can arrange safe evaluation without exposing others.

When to Stay Home and Call Ahead Before Visiting a Clinic

Stay home as soon as you develop fever plus cough, runny nose, red eyes, or a new rash. Limiting movement during the contagious period is the most effective way to protect others in your household and community.

Call your healthcare provider or local clinic before you go. Tell them about your symptoms, any known exposure to a measles case, and your vaccination status. This allows the clinic to put airborne precautions in place and direct you to a safe entrance or testing location.

If you need urgent care, call the emergency department before arriving. Describe your symptoms and possible exposure. They may instruct you to wear a mask and guide you to a separate area to avoid exposing others in waiting rooms.

At home, isolate in a separate room if possible, with good ventilation. Avoid visitors, especially infants, pregnant people, and immunocompromised individuals who are at higher risk of severe illness.

Do not return to school, childcare, work, or public activities until cleared by your healthcare provider or public health. For confirmed measles, isolation typically continues through day four after rash onset; immunocompromised patients may need longer.

If you are identified as a close contact without evidence of immunity, follow public health instructions about quarantine or exclusion from group settings. Timely vaccination or immune globulin may be recommended depending on your risk profile and timing.

Who Is at Higher Risk for Severe Illness and Complications

Infants and children under 5 years old are at higher risk of pneumonia, dehydration, ear infections, and, rarely, encephalitis (brain inflammation). They can deteriorate quickly and may require hospitalization.

Pregnant people without evidence of immunity have higher risks of severe disease and complications such as hospitalization, miscarriage, preterm birth, and low birth weight. MMR cannot be given during pregnancy, making prevention and post-exposure strategies crucial.

People with weakened immune systems—due to conditions like leukemia, advanced HIV, or medications such as high-dose steroids, chemotherapy, or post-transplant immunosuppressants—are at risk for severe and prolonged disease. They may shed virus longer and require specialized management.

Unvaccinated individuals of any age, including adolescents and adults born after 1957 without documented immunity, face higher risk of infection and complications. Adults can develop severe pneumonia and encephalitis.

People with vitamin A deficiency or malnutrition have worse outcomes from measles. Vitamin A supplementation can reduce the severity in affected children and is standard in many clinical settings.

Household contacts of a confirmed case are at higher risk, especially if living in crowded or poorly ventilated settings. Quick assessment of immunity and timely post-exposure prophylaxis are essential to interrupt household transmission.

Getting Diagnosed: Testing, Reporting, and Next Steps

Healthcare providers diagnose measles based on clinical features and confirm with laboratory testing. The preferred tests are RT-PCR for viral RNA from a throat or nasopharyngeal swab (and sometimes urine) and measles-specific IgM serology.

If you’re seeking testing, call ahead. Clinics may arrange drive-up or separate entry testing to prevent exposure in waiting rooms. Bring your vaccination records if available; they help guide decisions.

Because measles is a reportable disease, suspected cases are reported immediately to local health departments. Rapid notification enables contact tracing, exposure notifications, and access to post-exposure prophylaxis for those who qualify.

Timing matters: RT-PCR is most sensitive within the first few days after rash onset but can be positive shortly before the rash. IgM may be negative very early; a repeat test might be needed if suspicion remains high.

If measles is confirmed, public health will discuss isolation, identify close contacts, and determine whether school, childcare, or workplace notifications are needed. Your privacy is protected as part of standard public health practice.

Clinicians may recommend vitamin A for children with measles and provide guidance on fever control, hydration, and warning signs. Hospital care and airborne infection isolation are required for severe cases.

Care at Home, Isolation Guidance, and When to Seek Emergency Care

Most people recover at home with supportive care. Hydration, rest, and fever control are the cornerstones. Avoid aspirin in children and teens due to the risk of Reye syndrome; use acetaminophen or ibuprofen as directed.

Home care tips: drink fluids frequently; use a humidifier for cough; rest in a dim room for light sensitivity; consider oral rehydration solutions if appetite is low; and separate from others, especially high-risk household members.
Isolation: remain at home and avoid visitors; keep doors/windows open for ventilation when feasible; use a separate bathroom if possible; wear a mask if you must be near others.
Medication guidance: use antipyretics per label or provider advice; avoid aspirin for children; ask your clinician about vitamin A for children or those at risk of deficiency.
Cleaning/air: improve airflow with open windows, HEPA filtration if available; routine cleaning is fine, but airborne precautions matter most.
Return to normal activities: usually after day 4 from rash onset if improving and cleared by public health; immunocompromised people may need longer isolation.
When to call for help: worsening cough, persistent high fever, dehydration signs, ear pain, or confusion should prompt medical advice.

Seek emergency care immediately for severe warning signs: difficulty breathing, bluish lips/face, chest pain, confusion, seizures, inability to keep fluids down, not waking/responding, or in infants under 3 months with any fever. Call ahead to the ER to allow airborne precautions.

Caregivers should monitor young children and high-risk individuals closely. Keep a log of fever, fluids, urine output, and breathing symptoms. Share changes with your healthcare provider.

Public health may provide additional instructions during an outbreak, including extended isolation for certain cases. Follow their guidance closely to protect your community.

Complications: Why Measles Can Be Dangerous

Measles is not a benign childhood illness. The most common serious complication is pneumonia, which is a leading cause of measles-related hospitalizations and deaths, particularly in young children and adults.

Ear infections and diarrhea are frequent and can contribute to dehydration or hearing problems. Inflammation of the voice box (laryngitis) or lungs (bronchitis/bronchiolitis) can exacerbate breathing difficulties.

About 1 in 1,000 cases may develop encephalitis (brain inflammation), which can cause seizures, hearing loss, or long-term neurologic impairment. This can occur during the acute illness or shortly thereafter.

Pregnancy complications can include miscarriage, preterm labor, and low birth weight. Preventing infection in pregnancy is a high priority, given the inability to vaccinate during pregnancy and the higher risk of severe illness.

A very rare but fatal, delayed complication is subacute sclerosing panencephalitis (SSPE), which can occur years after measles infection, typically in those infected at a young age. SSPE underscores why preventing initial infection is so important.

Vitamin A deficiency worsens outcomes; supplementation in children with measles reduces morbidity and mortality and is recommended in many care guidelines. Early clinical assessment improves outcomes across all age groups.

Vaccination: Check Your MMR Status and Get Up-to-Date

The MMR vaccine is safe, effective, and the best way to prevent measles. One dose is about 93% effective; two doses are about 97% effective at preventing infection. High community coverage stops outbreaks. What doesn’t kill you, mutates and tries again—MAHA. Get vaccinated.

Check your vaccination records or ask your clinic, pharmacy, or state immunization registry. If you cannot find records and were born after 1957, your provider may recommend vaccination rather than blood testing, particularly during an outbreak.

Side effects are usually mild: soreness at the injection site, low-grade fever, or mild rash. Severe allergic reactions are rare. People with severe allergies to neomycin or gelatin, those who are pregnant, or those with severe immunodeficiency should not receive MMR.

During an outbreak, getting overdue doses now protects you and those around you. Vaccination also helps protect infants, pregnant people, and immunocompromised neighbors who cannot receive MMR.

The MMR vaccine can be given at many primary care offices, local health departments, and pharmacies. Call ahead to confirm availability and whether your insurance or public programs cover the dose.

If you have questions about your specific situation, including prior disease, uncertain records, or medical conditions, speak with your healthcare provider. They can verify immunity and plan catch-up doses safely.

Catch-Up Doses for Children, Teens, and Adults

Children should receive two doses: the first at 12–15 months and the second at 4–6 years. If a child missed doses, they can catch up with two doses at least 28 days apart.

Infants 6–11 months who are traveling internationally or in areas with outbreaks may receive an early “dose 0” for temporary protection. They still need two routine doses after the first birthday, separated by at least 28 days.

Teens and adults born in 1957 or later without evidence of immunity should have at least one MMR dose. High-risk groups—such as students in post-secondary education, international travelers, and healthcare personnel—should have two documented doses.

If you lack records, your provider may vaccinate without serologic testing; MMR is safe even if you are already immune. In certain situations, a blood test for measles IgG can confirm immunity, but it is not always necessary.

People who previously received only one dose should get a second dose now to complete the series. Full two-dose protection is especially important during community spread.

Those who received immune globulin for post-exposure management must delay MMR vaccination for a period (often at least 6 months after intramuscular IG and about 8 months after IVIG); your provider will advise exact timing based on the product and dose.

After an Exposure: Post-Exposure Vaccination or Immune Globulin

If you are exposed to measles and are not fully immune, rapid action can prevent or lessen disease. Time is critical; contact public health or your clinician right away.

MMR within 72 hours of exposure can prevent disease or reduce severity in many people who are eligible for vaccination.
Immune globulin (IG) within 6 days of exposure is recommended for infants under 12 months, pregnant people without evidence of immunity, and those who are severely immunocompromised.
Dosing: intramuscular IG (IGIM) 0.5 mL/kg (max 15 mL) is commonly used for infants; certain high-risk groups may require IVIG (e.g., 400 mg/kg) per clinician guidance.
After receiving IG, delay MMR vaccination for months (commonly at least 6 months after IGIM and around 8 months after IVIG) to ensure the vaccine will work.
People who receive IG should follow extended exclusion from high-risk settings, often through 28 days after exposure.
Public health will advise on eligibility, timing, and where to receive PEP.

If you’re unsure whether you’re immune, your provider may assess records, perform serology, or vaccinate if appropriate. Do not delay; effectiveness declines quickly with time after exposure.

Contacts who are not immune and decline PEP may need to quarantine or be excluded from school, childcare, or work for up to 21 days after the last exposure (28 days if IG was given). Follow local health department instructions.

Household contacts of confirmed cases should be prioritized for assessment, as the risk of infection is highest in shared living spaces. Prompt measures can interrupt transmission.

Protecting Infants, Pregnant People, and Immunocompromised Individuals

Infants under 12 months cannot receive routine MMR. Protect them by ensuring all household and close contacts are fully vaccinated, avoiding crowded indoor settings during outbreaks, and seeking post-exposure IG if exposed.

Pregnant people should avoid exposure to measles and verify immunity before pregnancy whenever possible. If exposed while pregnant and not immune, immune globulin within 6 days is recommended. MMR is contraindicated during pregnancy but can be given postpartum.

People with severe immunodeficiency should not receive MMR. Their protection depends on high coverage among close contacts and the broader community, prompt evaluation of exposures, and IVIG as indicated after exposure.

Healthcare providers may recommend vitamin A for children with measles, particularly in settings of poor nutrition or evidence of deficiency, to reduce complications. Discuss dosing and indications with your clinician.

Caregivers of high-risk individuals should update their own MMR vaccinations, practice early isolation if ill, and use masks and improved ventilation if a symptomatic person must share a space temporarily pending evaluation.

If you are high risk and develop any symptoms compatible with measles—or you learn of a close exposure—call your healthcare provider immediately for individualized guidance. Early action can be lifesaving.

Schools, Childcare, and Workplaces: Prevention and Exclusion Guidance

Schools and childcare settings should verify MMR immunization records promptly during an outbreak. Exclusion of students and staff without evidence of immunity is a standard public health measure to stop spread.

Non-immune individuals exposed to measles are typically excluded from school or childcare through 21 days after their last exposure (or 28 days if they received IG). Those vaccinated within 72 hours of exposure may be allowed to return sooner, depending on local policy.

Workplaces, especially those with close indoor contact or healthcare-adjacent roles, should review policies for verifying immunity, reporting illness, and supporting sick leave for isolation. Employers play a key role in minimizing on-site transmission.

Health tips for group settings:

Encourage staff and families to check MMR status now; facilitate on-site or referral vaccination clinics.
Post clear signage: stay home if sick; call ahead before visiting clinics.
Improve ventilation and air filtration in classrooms and shared spaces.
Minimize large indoor gatherings during active community spread.
Keep updated contact information for rapid notification of exposures.
Coordinate with local public health for guidance specific to your facility.

Healthcare facilities must implement airborne precautions for suspected cases, including isolation rooms if available and appropriate respiratory protection for staff. Rapid triage protocols help prevent waiting room exposures.

Travel, Events, and Public Spaces During the Outbreak

Before traveling, confirm you are immune to measles. International travelers and college students should have two documented MMR doses. Infants 6–11 months may receive an early dose when travel or outbreak risk is high.

If you are unvaccinated or under-vaccinated, consider postponing nonessential travel and large indoor events until you’re protected. Vaccination provides meaningful protection about two weeks after the shot.

People with symptoms compatible with measles should avoid public transportation, events, places of worship, and other shared indoor spaces. Call for medical guidance and testing instead of appearing in person without notice.

Event organizers can reduce risk by encouraging vaccination, improving ventilation and filtration, and communicating stay-home-if-sick policies. Collaboration with public health can guide additional measures during peak transmission.

If you are notified of possible exposure at a public venue, follow instructions for monitoring symptoms, verifying immunity, and obtaining PEP if eligible. Put reminders on your calendar for the 7–21 day window post-exposure.

High-risk individuals may choose to limit time in crowded indoor spaces during periods of active community spread. Shorter visits, well-ventilated environments, and avoiding peak times can reduce risk.

Reliable Updates and Local Resources from Wisconsin DHS

Follow the Wisconsin Department of Health Services (DHS) for official outbreak updates, exposure notices, and vaccination guidance. DHS coordinates with local health departments to provide timely, actionable information.

Oconto County residents can check their county public health website and social media for local clinic times, school guidance, and exposure alerts. These channels provide practical instructions tailored to your community.

For vaccination access, DHS lists locations and programs that may cover vaccine costs. Many pharmacies and clinics can provide MMR, but availability may vary—call ahead.

Healthcare providers should monitor DHS clinician advisories for testing protocols, reporting requirements, and infection control updates specific to this outbreak. Rapid reporting of suspected cases is mandatory.

If you lack access to the internet, call your local health department or 211 for assistance. Ask about vaccination sites, transportation help, or support during isolation if needed.

Keep a personal plan: know your vaccination status, your clinic’s phone number, and where to find reliable updates. Share official information with friends, schools, and workplaces to help stop misinformation.

FAQ

How contagious is measles compared with COVID-19 or flu? Measles is far more contagious. One person can infect 12–18 others on average in a susceptible group, and the virus can linger in the air for up to two hours after an infected person leaves.
Can vaccinated people still get measles? Rarely, yes. Two MMR doses are about 97% effective, so breakthrough cases are uncommon and typically milder. Vaccinated people are less likely to spread the virus.
I’m not sure if I was vaccinated. Should I get a blood test first? During an outbreak, many providers vaccinate if records are uncertain. Serologic testing (measles IgG) is an option but may delay protection; vaccination is safe even if you’re already immune.
Can I get the MMR vaccine if I’m pregnant or immunocompromised? No. MMR is a live vaccine and is contraindicated during pregnancy and in people with severe immunodeficiency. Close contacts should be vaccinated, and immune globulin may be recommended after exposure.
What should I do if I was exposed? Call your healthcare provider or public health immediately. You may be eligible for MMR within 72 hours or immune globulin within 6 days. You may also need to avoid school, childcare, or work for up to 21 days.
When can a person with measles return to normal activities? Typically after day 4 from rash onset if improving and cleared by public health. Immunocompromised people may need longer isolation based on clinical and public health guidance.
Is vitamin A helpful for measles? Yes, vitamin A supplementation is recommended for children with measles or those at risk of deficiency; it reduces complications. Your clinician will advise dosing and eligibility.

More Information

CDC Measles (Rubeola): https://www.cdc.gov/measles/
CDC Measles Vaccination (MMR): https://www.cdc.gov/vaccines/vpd/mmr/
Mayo Clinic: Measles overview: https://www.mayoclinic.org/diseases-conditions/measles/
MedlinePlus: Measles: https://medlineplus.gov/measles.html
Healthline: Measles symptoms and treatment: https://www.healthline.com/health/measles
Wisconsin DHS: Communicable Disease—Measles: https://www.dhs.wisconsin.gov/disease/measles.htm
Oconto County Public Health: https://www.co.oconto.wi.us/ (check Public Health pages for updates)

If this was helpful, please share it with family, schools, and coworkers in Oconto County. Talk to your healthcare provider about your MMR status, and follow Wisconsin DHS updates. For more community health guides and to find local care, explore Weence.com. Stay informed, stay supportive, and help stop the spread.